Agreement with Relational Technology Solutions Provides Hospitals with
Financial Flexibility for their Purchase of Niobe(R) Magnetic Robotic Systems
ST. LOUIS, March 12 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq:
STXS) today announced that it has reached an agreement with Relational
Technology Solutions (RTS) that will allow the Company to offer its hospital
customers an alternative financing arrangement for their purchase of
Stereotaxis Niobe(R) magnetic robotic systems. Under the agreement, hospitals
will be able to fund a Niobe purchase through monthly operating lease
payments.
"With this agreement with RTS, Stereotaxis is able to offer hospital
administrators enhanced financial flexibility in their purchase of a
Stereotaxis system," said Mike Kaminski, Stereotaxis President and CEO. "The
operating lease arrangement is an attractive alternative which allows
customers to match revenue growth in EP with new technology costs. RTS is
very well-regarded in the industry, and we are very happy to be working with
the firm to provide our customers with financing alternatives."
"Based on Stereotaxis' unique approach to treating coronary-related
diseases and established presence in the healthcare market, Relational
Technology Solutions is pleased to enter into a formal partnership with such
an innovative company," said Jeff Ehlers, Chief Executive Officer at RTS. "In
the current economic environment, it's important that hospitals maintain the
financial options necessary to acquire innovative medical technologies that
not only improve patient care but are also cost effective. RTS looks forward
to working with these organizations and creating custom financing solutions,
which will enable them to obtain Stereotaxis technology and maintain a
competitive advantage." Relational Technology Solutions currently manages a
one billion dollar equipment portfolio spanning medical, IT and
telecommunications assets, and provides extensive coverage of the U.S. and
Canadian medical equipment capital markets.
About Stereotaxis
Stereotaxis designs, manufactures and markets an advanced cardiology
instrument control system for use in a hospital's interventional surgical
suite to enhance the treatment of coronary artery disease and arrhythmias. The
Stereotaxis System is designed to enable physicians to complete more complex
interventional procedures by providing image guided delivery of catheters and
guidewires through the blood vessels and chambers of the heart to treatment
sites. This is achieved using computer-controlled, externally applied magnetic
fields that govern the motion of the working tip of the catheter or guidewire,
resulting in improved navigation, shorter procedure time and reduced x-ray
exposure. The core components of the Stereotaxis system have received
regulatory clearance in the U.S., Europe and Canada.
About Forward Looking Statements
This press release includes statements that may constitute "forward-
looking" statements, usually containing the words "believe," "estimate,"
"project," "expect" or similar expressions. Forward-looking statements
inherently involve risks and uncertainties that could cause actual results to
differ materially from the forward-looking statements. Factors that would
cause or contribute to such differences include, but are not limited to,
continued acceptance for the Company's products in the marketplace,
competitive factors, changes in government reimbursement procedures,
dependence upon third-party vendors, and other risks discussed in the
Company's periodic and other filings with the Securities and Exchange
Commission. By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes after the
date of this release. There can be no assurance that we will recognize revenue
related to our purchase orders and other commitments in any particular period
or at all because some of these purchase orders and other commitments are
subject to contingencies that are outside of our control. In addition, these
orders and commitments may be revised, modified or canceled, either by their
express terms, as a result of negotiations, or by project changes or delays.
http://www.stereotaxis.com/
SOURCE Stereotaxis, Inc.
-0- 03/12/2009
/CONTACT: Company, Jim Stolze, Chief Financial Officer of Stereotaxis,
Inc., +1-314-678-6105; or Investors, Doug Sherk, or Jenifer Kirtland, both at
+1-415-896-6820, or Media, Steve DiMattia, +1-646-201-5445, all of EVC Group,
Inc., for Stereotaxis, Inc./
/Web Site: http://www.stereotaxis.com /
(STXS)
CO: Stereotaxis, Inc.; Relational Technology Solutions
ST: Missouri
IN: MEQ HEA
SU: LIC
PR
-- SF82722 --
4322 03/12/200906:30 EDThttp://www.prnewswire.com